BofA analyst Derik de Bruin lowered the firm’s price target on Charles River to $230 from $245 and keeps a Buy rating on the shares after management used their analyst day to adjust midterm financial targets. The firm believes the “tempered” margin and growth outlooks – including updated guidance that calls for a 6-8% organic growth CAGR and about 150 basis points of operating margin expansion by FY26 – were broadly expected by investors and reflect a more appropriate view of underlying fundamentals, adding that the meeting “efficiently highlighted the diversity” of Charles River’s business and potential.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRL:
- Charles River’s updated targets below consensus expectations, says UBS
- Charles River says ‘well positioned to deliver 6%-8% organic revenue growth
- Charles River enters multi-program collaboration pact utilizing Logica
- Charles River initiated with a Market Perform at TD Cowen
- Charles River, PathoQuest validate sequencing viral safety assay as option